Metacrine, Inc.
(NASDAQ CM: MTCR)
Rigrodsky Law, P.A. is investigating Metacrine, Inc. (“Metacrine”) regarding possible breaches of fiduciary duties and other violations of law related to Metacrine’s agreement to be acquired by Equillium, Inc. in an all-stock transaction.